Riegel W, Hörl W H
Medizinische Universitätsklinik IV, Homburg/Saar.
Infection. 1993;21 Suppl 1:S14-6. doi: 10.1007/BF01710338.
Forty-one hospitalized patients were randomized to be treated with cefuroxime (4.05 g/die) or cefotiam (5.30 g/die). Several patients received additionally furosemide (0.5 mg/kg body weight) intravenously. Serum creatinine and creatinine clearance did not show significant differences during versus after treatment in any of the groups. Cefotiam or cefotiam/furosemide treated patients displayed higher proteinuria and higher urinary excretion of lysosomal enzymes (leucine aminopeptidase) than patients treated with cefuroxime or cefuroxime/furosemide. Our data indicate higher tubulotoxicity of cefotiam compared to cefuroxime.
41名住院患者被随机分为两组,分别接受头孢呋辛(4.05克/天)或头孢替安(5.30克/天)治疗。部分患者还额外静脉注射了速尿(0.5毫克/千克体重)。在任何一组中,治疗期间与治疗后血清肌酐和肌酐清除率均无显著差异。与接受头孢呋辛或头孢呋辛/速尿治疗的患者相比,接受头孢替安或头孢替安/速尿治疗的患者蛋白尿更高,溶酶体酶(亮氨酸氨肽酶)尿排泄量更高。我们的数据表明,与头孢呋辛相比,头孢替安的肾小管毒性更高。